United-Guardian — Q3 2026 Earnings Summary

United-Guardian, Inc. reported a 54% increase in third-quarter net sales to $3,494,780 and a 247% rise in net income to $930,912 for the period ended September 30, 2026. Pharmaceutical sales grew 29% driven by Renacidin, while cosmetic ingredient sales surged 187% due to increased purchases from Ashland Specialty Ingredients. For the first nine months of 2026, net sales reached $9,475,269, representing a 25% increase, with net income climbing 70% to $2,478,393.